FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to 5-FU
Related studies linked through entity extraction aliases.
Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
- Status
- TERMINATED
- Phase
- PHASE2
Trimodality Management of T1b Esophageal Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of IMC-11F8 in Participants With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
- Status
- COMPLETED
- Phase
- PHASE2